0000814133-24-000021.txt : 20240209 0000814133-24-000021.hdr.sgml : 20240209 20240209124020 ACCESSION NUMBER: 0000814133-24-000021 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240209 DATE AS OF CHANGE: 20240209 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Intra-Cellular Therapies, Inc. CENTRAL INDEX KEY: 0001567514 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 364742850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-87380 FILM NUMBER: 24613562 BUSINESS ADDRESS: STREET 1: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 212-923-3344 MAIL ADDRESS: STREET 1: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: Oneida Resources Corp. DATE OF NAME CHANGE: 20130122 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: WASATCH ADVISORS LP CENTRAL INDEX KEY: 0000814133 ORGANIZATION NAME: IRS NUMBER: 870319391 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 505 WAKARA WAY STREET 2: 3RD FLOOR CITY: SALT LAKE CITY STATE: UT ZIP: 84108 BUSINESS PHONE: 8015330777 MAIL ADDRESS: STREET 1: 505 WAKARA WAY STREET 2: 3RD FLOOR CITY: SALT LAKE CITY STATE: UT ZIP: 84108 FORMER COMPANY: FORMER CONFORMED NAME: WASATCH ADVISORS INC DATE OF NAME CHANGE: 19990611 SC 13G/A 1 itci224.txt SCHEDULE 13G Amendment No. 4 Name of Issuer: Intra-Cellular Therapies, Inc. Title of Class of Securities: Common Stock CUSIP Number: 46116X101 Item 1: Reporting Person: Wasatch Advisors LP 87-0319391 Item 2: Check Box If Member of Group: Not Applicable Item 3: SEC Use Item 4: Place of Organization: Utah Items 5-8: Number of Shares Owned With: Item 5: Sole Voting Power: 3,627,308 Item 6: Shared Voting Power: 0 Item 7: Sole Dispositive Power: 3,627,308 Item 8: Shared Dispositive Power: 0 Item 9: Aggregate Amount Owned: 3,627,308 Item 10: Check Box If Aggregate Amount Excludes Certain Shares: N/A Item 11: Percent of Class Owned: 3.8% Item 12: Type of Reporting Person: IA Item 1(a): Name of Issuer: Intra-Cellular Therapies, Inc. Item l(b): Address of Issuer: 430 East 29th Street, New York, NY 10016 Item 2(a): Name of Person Filing: Wasatch Advisors LP Item 2(b): Address: 505 Wakara Way, Salt Lake City, UT 84108 Item 2(c): Citizenship: Not Applicable Item 2(d): Title of Class of Securities: Common Stock Item 2(e): CUSIP Number: 46116X101 Item 3(e): Investment Adviser registered under section 203 of the Investment Advisers Act of 1940 Item 4(a): Amount Owned: 3,627,308 Item 4(b): Percent of Class Owned: 3.8% Item 4(c)(i): Sole Voting Power: 3,627,308 Item 4(c)(ii): Shared Voting Power: 0 Item 4(c)(iii): Sole Dispositive Power: 3,627,308 Item 4(c)(iv): Shared Dispositive Power: 0 Item 5: Check Box If Ownership Is 5% or Less of Class: [X] Item 6. Ownership of More Than 5% on Behalf of Another Person: N/A Item 7: Identification of Subsidiary: Not Applicable Item 8: Identification of Members of Group: Not Applicable Item 9: Notice of Dissolution of Group: Not Applicable Item 10: Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct as of December 31, 2023. Date: 02/09/24 Signature: /s/JB Taylor Name/Title: JB Taylor/CEO